Cellect Biotechnology Ltd. - American Depositary Shares Company Profile (NASDAQ:APOP)

About Cellect Biotechnology Ltd. - American Depositary Shares (APOP)

Cellect Biotechnology Ltd. - American Depositary Shares logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: APOP
  • CUSIP: N/A
Key Metrics:
  • Previous Close: $5.94
  • 50 Day Moving Average: $5.82
  • 200 Day Moving Average: $4.29
  • 52-Week Range: $2.30 - $8.78
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.99
  • P/E Growth: 0.00
  • Market Cap: $33.67M
  • Outstanding Shares: 5,379,000
Debt:
  • Current Ratio: 4.25%
  • Quick Ratio: 4.25%

Analyst Ratings

Consensus Ratings for Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ:APOP) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (68.35% upside)

Analysts' Ratings History for Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ:APOP)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/22/2017HC WainwrightSet Price TargetBuy$10.00N/AView Rating Details
11/10/2016Rodman & RenshawInitiated CoverageBuy$10.00N/AView Rating Details
(Data available from 3/23/2015 forward)

Earnings

Earnings History for Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ:APOP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ:APOP)
Current Year EPS Consensus Estimate: $-1.01 EPS
Next Year EPS Consensus Estimate: $-0.85 EPS

Dividends

Dividend History for Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ:APOP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ:APOP)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ:APOP)
Latest Headlines for Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ:APOP)
Source:
DateHeadline
finance.yahoo.com logoCellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results (NASDAQ:APOP)
finance.yahoo.com - March 23 at 3:59 PM
finance.yahoo.com logoMichael Berelowitz MD., Former Head, Clinical Development and Medical Affairs, Pfizer Specialty Care Business Unit Joins Cellect’s Board of Directors (NASDAQ:APOP)
finance.yahoo.com - March 2 at 3:50 PM
finance.yahoo.com logoWorld-Renowned Stem Cell Transplantation Expert joins Cellect’s Advisory Board (NASDAQ:APOP)
finance.yahoo.com - February 23 at 3:36 PM
finance.yahoo.com logoCellect Biotechnology Ltd. (Nasdaq: APOP) to Ring The Nasdaq Stock Market Opening Bell (NASDAQ:APOP)
finance.yahoo.com - February 23 at 3:36 PM
finance.yahoo.com logoCellect to Ring the NASDAQ Stock Market Opening Bell on Friday, February 24th (NASDAQ:APOP)
finance.yahoo.com - February 23 at 3:36 PM
finance.yahoo.com logoCellect Announces Positive Clinical Trial Results (NASDAQ:APOP)
finance.yahoo.com - February 21 at 8:31 AM
finance.yahoo.com logoBiotech Industry Poised for a Breakout in 2017? Today's Reports on Cellect Biotechnology and XOMA (NASDAQ:APOP)
finance.yahoo.com - February 16 at 8:30 AM
finance.yahoo.com logoDual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange (NASDAQ:APOP)
finance.yahoo.com - February 14 at 4:12 PM
streetinsider.com logoCellect Biotechnology (APOP) Says It Treated First Blood Cancer Patient in Phase I/II Trial of ApoGraft (NASDAQ:APOP)
www.streetinsider.com - February 9 at 1:52 AM
us.rd.yahoo.com logoFirst Cancer Patient Treated In Phase I/II Trial of ApoGraft™ (NASDAQ:APOP)
us.rd.yahoo.com - February 8 at 3:47 PM
fool.com logoWhy Cellect Biotechnology Ltd Shares Skyrocketed Higher Today (NASDAQ:APOP)
www.fool.com - February 8 at 3:47 PM
finance.yahoo.com logoMergers & Acquisitions Could be a Key Catalyst for Biotech Stocks in 2017: Today's Reports on Cellect Biotechnology and Celldex Therapeutics (NASDAQ:APOP)
finance.yahoo.com - February 3 at 3:43 PM
streetinsider.com logoCellect Biotechnology (APOP) Names Dr. Yaron Pereg as CDO (NASDAQ:APOP)
www.streetinsider.com - January 31 at 2:38 AM
finance.yahoo.com logoDr. Yaron Pereg Appointed as New Chief Development Officer (NASDAQ:APOP)
finance.yahoo.com - January 30 at 4:36 PM
finanznachrichten.de logoGainers & Losers Of The Day: TBIO, IMMU, SGMO, BIOC, APRI (NASDAQ:APOP)
www.finanznachrichten.de - January 13 at 1:38 AM
rttnews.com logoCellect Biotechnology Ltd. (APOP) Is Surging On Patent News (NASDAQ:APOP)
www.rttnews.com - January 12 at 8:38 PM
us.rd.yahoo.com logoCellect Receives Patent Notice of Allowance from US Patent & Trademark Office Protecting Company’s Technology in Multiple Key Indications (NASDAQ:APOP)
us.rd.yahoo.com - January 12 at 3:37 PM
finance.yahoo.com logoMajor Shareholder Buying Shares (NASDAQ:APOP)
finance.yahoo.com - January 9 at 3:47 PM
seekingalpha.com logoCellect appoints Eyal Leibovitz as CFO (NASDAQ:APOP)
seekingalpha.com - January 4 at 2:13 AM
streetinsider.com logoCellect Biotechnology Ltd. (APOP) Names Eyal Leibovitz as CFO (NASDAQ:APOP)
www.streetinsider.com - January 4 at 2:13 AM
us.rd.yahoo.com logoCellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer (NASDAQ:APOP)
us.rd.yahoo.com - January 3 at 4:08 PM
us.rd.yahoo.com logo8:04 am Cellect Biotechnology appoints Eyal Leibovitz as CFO (NASDAQ:APOP)
us.rd.yahoo.com - January 3 at 4:08 PM
finance.yahoo.com logoLifeSci Capital Initiates Coverage of Cellect Biotechnology (NASDAQ:APOP)
finance.yahoo.com - December 7 at 9:04 PM
finance.yahoo.com logoCellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2016 Financial Results (NASDAQ:APOP)
finance.yahoo.com - November 29 at 2:38 PM
finance.yahoo.com logoCellect signs agreement with the Hadassah Technological Transfer Company – Hadasit (NASDAQ:APOP)
finance.yahoo.com - November 23 at 12:46 PM
finance.yahoo.com logo10:47 am Cellect Biotechnology (thinly-traded) signs agreement with Hadasit for a series of trials using its ApoGraft method to test engraftment potential and its effect on lowering GvHD in mice models (NASDAQ:APOP)
finance.yahoo.com - November 23 at 12:46 PM
finance.yahoo.com logoCoverage initiated on Cellect Biotechnology by Rodman & Renshaw (NASDAQ:APOP)
finance.yahoo.com - November 10 at 2:02 PM
streetinsider.com logoForm 6-K Cellect Biotechnology For: Sep 26 (NASDAQ:APOP)
www.streetinsider.com - September 26 at 8:16 AM

Social

Frequently Asked Questions for Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ:APOP)

What is Cellect Biotechnology Ltd. - American Depositary Shares' stock symbol?

Cellect Biotechnology Ltd. - American Depositary Shares trades on the NASDAQ under the ticker symbol "APOP."

Where is Cellect Biotechnology Ltd. - American Depositary Shares' stock going? Where will Cellect Biotechnology Ltd. - American Depositary Shares' stock price be in 2017?

2 brokers have issued twelve-month price targets for Cellect Biotechnology Ltd. - American Depositary Shares' shares. Their forecasts range from $10.00 to $10.00. On average, they anticipate Cellect Biotechnology Ltd. - American Depositary Shares' share price to reach $10.00 in the next twelve months.

When did Cellect Biotechnology Ltd. - American Depositary Shares' lock-up period expire?

Cellect Biotechnology Ltd. - American Depositary Shares' lock-up period expired on Wednesday, January 25th. Cellect Biotechnology Ltd. - American Depositary Shares had issued 1,292,308 shares in its initial public offering on July 29th. The total size of the offering was $8,400,002 based on an initial share price of $6.50. Since the end of Cellect Biotechnology Ltd. - American Depositary Shares' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Who owns Cellect Biotechnology Ltd. - American Depositary Shares stock?

Cellect Biotechnology Ltd. - American Depositary Shares' stock is owned by many different of retail and institutional investors. Top institutional investors include CHIRICH KASBIAN NURIEL (15.80%) and YARKONI SHAI (14.20%).

How do I buy Cellect Biotechnology Ltd. - American Depositary Shares stock?

Shares of Cellect Biotechnology Ltd. - American Depositary Shares can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cellect Biotechnology Ltd. - American Depositary Shares stock cost?

One share of Cellect Biotechnology Ltd. - American Depositary Shares stock can currently be purchased for approximately $5.94.

Cellect Biotechnology Ltd. - American Depositary Shares (APOP) Chart for Thursday, March, 23, 2017

This page was last updated on 3/23/2017 by MarketBeat.com Staff